Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. 8-K Event Results of operations
  2. 10-Q Report Quarterly Report
  3. 8-K Event Material agreement · Shareholder rights changed · Other events
  4. 8-K Event Other events
  5. 8-K Event Regulation FD disclosure
  6. 8-K Event Results of operations
  7. 10-Q Report Quarterly Report
  8. 424B5 Offering Prospectus
  9. 8-K Event Material agreement
  10. 4 Grant or award Director acquired 10,000 shares (grant or award)
  11. 4 Grant or award Director acquired 10,000 shares (grant or award)
  12. 4 Grant or award Director acquired 10,000 shares (grant or award)
  13. 4 Grant or award Director acquired 10,000 shares (grant or award)
  14. 4 Grant or award Director acquired 10,000 shares (grant or award)
  15. 4 Grant or award Director acquired 10,000 shares (grant or award)
  16. 8-K Event Exhibits
  17. 10-Q Report Quarterly Report
  18. 8-K Event Shareholder vote results
  19. 8-K Event Other events
  20. 4 Grant or award President & CEO acquired 65,000 shares (grant or award)

Page 1 of 33 · 643 filings